1887

Abstract

To assess the effects of constitutive hepatitis C virus (HCV) gene expression on liver, transgenic mice carrying the entire HCV open reading frame inserted in the 1 antitrypsin (A1AT) gene were generated. Expression of A1AT/HCV mRNA was found to be mainly limited to perivascular areas of the liver as indicated by hybridization analysis. HCV core protein was detected in Western blots of liver extracts, whereas the expression of E2, NS3 and NS5 proteins was revealed by immunostaining of liver samples using HCV-specific antisera. Histological analysis of HCV transgenic mice showed that these animals develop extensive steatosis, but very little necrosis of liver tissue. Moreover, a consistent T cell infiltrate and a slight hepatocyte proliferation were observed. Phenotypic analysis of cells infiltrating the liver indicated that recruitment and/or expansion of residing CD8, NK, NKT and T cells occurred in transgenic animals. Among these cells, a large fraction of CD8 T lymphocytes released mainly IL-10 and, to a lesser extent, IFN- upon mitogenic stimulation . Furthermore, both intrahepatic lymphocytes and splenocytes did not produce cytokines in response to HCV antigens. Thus, these data indicate that constitutive expression of HCV proteins may be responsible for intrahepatic lymphocyte recruitment in absence of viral antigen recognition. This response is likely to be driven by virus-induced cellular factors and may play a significant role in the immunopathology of chronic HCV infection and liver disease.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.19724-0
2004-06-01
2020-01-19
Loading full text...

Full text loading...

/deliver/fulltext/jgv/85/6/vir851509.html?itemId=/content/journal/jgv/10.1099/vir.0.19724-0&mimeType=html&fmt=ahah

References

  1. Agrati, C., D'Offizi, G., Narciso, P., Abrignani, S., Ippolito, G., Colizzi, V. & Poccia, F. ( 2001; ). Vδ1 T lymphocytes expressing a Th1 phenotype are the major γδT cell subset infiltrating the liver of HCV-infected persons. Mol Med 7, 11–19.
    [Google Scholar]
  2. Akdis, C. A. & Blaser, K. ( 2001; ). Mechanisms of interleukin-10-mediated immune suppression. Immunology 103, 131–136.[CrossRef]
    [Google Scholar]
  3. Amicone, L., Galimi, M. A., Spagnoli, F. M., Tommasini, C., De Luca, V. & Tripodi, M. ( 1995; ). Temporal and tissue-specific expression of the MET ORF driven by the complete transcriptional unit of human A1AT gene in transgenic mice. Gene 162, 323–328.[CrossRef]
    [Google Scholar]
  4. Amicone, L., Spagnoli, F. M., Spath, G. & 8 other authors ( 1997; ). Transgenic expression in the liver of truncated Met blocks apoptosis and permits immortalization of hepatocytes. EMBO J 16, 495–503.[CrossRef]
    [Google Scholar]
  5. Armstrong, G. L., Alter, M. J., McQuillan, G. M. & Margolis, H. S. ( 2000; ). The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States. Hepatology 31, 777–782.[CrossRef]
    [Google Scholar]
  6. Bach, N., Thung, S. N. & Schaffner, F. ( 1992; ). The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis. Hepatology 15, 572–577.[CrossRef]
    [Google Scholar]
  7. Bertoletti, A. & Maini, M. K. ( 2000; ). Protection or damage: a dual role for the virus-specific cytotoxic T lymphocyte response in hepatitis B and C infection? Curr Opin Microbiol 3, 387–392.[CrossRef]
    [Google Scholar]
  8. Bianchi, L., Desmet, V. J., Popper, H., Scheuer, P. J., Aledort, L. M. & Berk, P. D. ( 1987; ). Histologic patterns of liver disease in hemophiliacs, with special reference to morphologic characteristics of non-A, non-B hepatitis. Semin Liver Dis 7, 203–209.[CrossRef]
    [Google Scholar]
  9. Blindenbacher, A., Duong, F. H., Hunziker, L. & 9 other authors ( 2003; ). Expression of hepatitis C virus proteins inhibits interferon α signalling in the liver of transgenic mice. Gastroenterology 124, 1465–1475.[CrossRef]
    [Google Scholar]
  10. Bloch, B. ( 1993; ). Biotinylated probes for in situ hybridization histochemistry: use for mRNA detection. J Histochem Cytochem 41, 1751–1754.[CrossRef]
    [Google Scholar]
  11. Cerny, A. & Chisari, F. V. ( 1999; ). Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence. Hepatology 30, 595–601.[CrossRef]
    [Google Scholar]
  12. Choo, Q. L., Kuo, G., Weiner, A. J., Overby, L. R., Bradley, D. W. & Houghton, M. ( 1989; ). Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244, 359–362.[CrossRef]
    [Google Scholar]
  13. Choo, Q. L., Richman, K. H. Han, J. H. & 11 other authors ( 1991; ). Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci U S A 8, 2451–2455.
    [Google Scholar]
  14. Clarke, B. ( 1997; ). Molecular virology of hepatitis C virus. J Gen Virol 78, 2397–2410.
    [Google Scholar]
  15. Duong, F. H., Filipowicz, M., Tripodi, M., La Monica, N. & Heim, M. H. ( 2004; ). Hepatitis C virus inhibits interferon signaling through up-regulation of protein phosphatase 2A. Gastroenterology 126, 263–277.[CrossRef]
    [Google Scholar]
  16. Eckart, M. R., Selby, M., Masiarz, F. & 7 other authors ( 1993; ). The hepatitis C virus encodes a serine protease involved in processing of the putative nonstructural proteins from the viral polyprotein precursor. Biochem Biophys Res Commun 192, 399–406.[CrossRef]
    [Google Scholar]
  17. Esposito, G., Scarselli, E., Cerino, A., Mondelli, M. U., La Monica, N. & Traboni, C. ( 1995; ). A human antibody specific for hepatitis C virus core protein: synthesis in a bacterial system and characterization. Gene 164, 203–209.[CrossRef]
    [Google Scholar]
  18. Fimia, G. M., Tripodi, M. & Alonzi, T. ( 2003; ). Transgenic models for hepatitis C virus pathogenesis. Cell Death Differ 10, S16–18.[CrossRef]
    [Google Scholar]
  19. Gerlach, J. T., Diepolder, H. M. Jung, M. C. & 7 other authors ( 1999; ). Recurrence of hepatitis C virus after loss of virus-specific CD4+ T-cell response in acute hepatitis C. Gastroenterology 117, 933–941.[CrossRef]
    [Google Scholar]
  20. Ghosh, A. K., Steele, R., Meyer, K., Ray, R. & Ray, R. B. ( 1999; ). Hepatitis C virus NS5A protein modulates cell cycle regulatory genes and promotes cell growth. J Gen Virol 80, 1179–1183.
    [Google Scholar]
  21. Gonzales-Peralta, R. P., Davis, G. L. & Lau, J. Y. ( 1994; ). Pathogenic mechanism of hepatocellular damage in chronic hepatitis C. J Hepatol 21, 255–259.[CrossRef]
    [Google Scholar]
  22. Grakoui, A., Wychowski, C., Lin, C., Feinstone, S. M. & Rice, C. M. ( 1993; ). Expression and identification of hepatitis C virus polyprotein cleavage products. J Virol 67, 1385–1395.
    [Google Scholar]
  23. Griffin, S. D. C., Harvey, R., Clarke, D. S., Barclay, W. S., Harris, M. & Rowlands, D. J. ( 2004; ). A conserved basic loop in hepatitis C virus p7 protein is required for amantadine-sensitive ion-channel activity in mammalian cells but is dispensable for localization to mitochondria. J Gen Virol 85, 451–461.[CrossRef]
    [Google Scholar]
  24. Gruner, N. H., Gerlach, T. J., Jung, M. C. & 9 other authors ( 2000; ). Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C. J Infect Dis 181, 1528–1536.[CrossRef]
    [Google Scholar]
  25. Hijikata, M., Mizushima, H., Akagi, T., Mori, S., Kakiuchi, N., Kato, N., Tanaka, T., Kimura, K. & Shimotohno, K. ( 1993a; ). Two distinct proteinase activities required for the processing of a putative nonstructural precursor protein of hepatitis C virus. J Virol 67, 4665–4675.
    [Google Scholar]
  26. Hijikata, M., Mizushima, H., Tanji, Y., Komoda, Y., Hirowatari, Y., Akagi, T., Kato, N., Kimura, K. & Shimotohno, K. ( 1993b; ). Proteolytic processing and membrane association of putative nonstructural proteins of hepatitis C virus. Proc Natl Acad Sci U S A 90, 10773–10777.[CrossRef]
    [Google Scholar]
  27. Hogan, B., Costantini, F. & Lacey, E. ( 1996; ). Manipulating the Mouse Embryo. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
  28. Houghton, M., Weiner, A., Han, J., Kuo, G. & Choo, Q. L. ( 1991; ). Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease. Hepatology 14, 381–388.[CrossRef]
    [Google Scholar]
  29. Kato, N., Hijikata, M., Ootsuyama, Y., Nakagawa, M., Ohkoshi, S., Sugimura, T. & Shimotohno, K. ( 1990; ). Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc Natl Acad Sci U S A 87, 9524–9528.[CrossRef]
    [Google Scholar]
  30. Koike, K. ( 1999; ). Transgenic mouse models of viral hepatitis: insight into viral hepatocarcinogenesis. Viral Hepatol 5, 177–203.
    [Google Scholar]
  31. Kuo, G., Choo, Q. L., Alter, H. J. & 17 other authors ( 1989; ). An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244, 362–364.[CrossRef]
    [Google Scholar]
  32. Lauer, G. M. & Walker, B. D. ( 2001; ). Hepatitis C virus infection. N Engl J Med 345, 41–52.[CrossRef]
    [Google Scholar]
  33. Lerat, H., Honda, M., Beard, M. R. & 7 other authors ( 2002; ). Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus. Gastroenterology 122, 352–365.[CrossRef]
    [Google Scholar]
  34. Lin, C., Pragai, B. M., Grakoui, A., Xu, J. & Rice, C. M. ( 1994; ). Hepatitis C virus NS3 serine proteinase: trans-cleavage requirements and processing kinetics. J Virol 68, 8147–8157.
    [Google Scholar]
  35. Marusawa, H., Hijikata, M., Chiba, T. & Shimotohno, K. ( 1999; ). Hepatitis C virus core protein inhibits Fas- and tumor necrosis factor alpha-mediated apoptosis via NF-κB activation. J Virol 73, 4713–4720.
    [Google Scholar]
  36. Mizushima, H., Hijikata, M., Asabe, S., Hirota, M., Kimura, K. & Shimotohno, K. ( 1994; ). Two hepatitis C virus glycoprotein E2 products with different C termini. J Virol 68, 6215–6222.
    [Google Scholar]
  37. Moore, K. W., de Waal Malefyt, R., Coffman, R. L. & O'Garra, A. ( 2001; ). Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19, 683–765.[CrossRef]
    [Google Scholar]
  38. Moriya, K., Yotsuyanagi, H., Shintani, Y., Fujie, H., Ishibashi, K., Matsuura, Y., Miyamura, T. & Koike, K. ( 1997; ). Hepatitis C virus core protein induces hepatic steatosis in transgenic mice. J Gen Virol 78, 1527–1531.
    [Google Scholar]
  39. Moriya, K., Nakagawa, K., Santa, T. & 11 other authors ( 2001; ). Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis. Cancer Res 61, 4365–4370.
    [Google Scholar]
  40. Napoli, J., Bishop, G. A., McGuinness, P. H., Painter, D. M. & McCaughan, G. W. ( 1996; ). Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines. Hepatology 24, 759–765.[CrossRef]
    [Google Scholar]
  41. Nelson, D. R., Tu, Z., Soldevila-Pico, C., Abdelmalek, M., Zhu, H., Xu, Y. L., Cabrera, R., Liu, C. & Davis, G. L. ( 2003; ). Long-term interleukin 10 therapy in chronic hepatitis C patients has a proviral and anti-inflammatory effect. Hepatology 38, 859–868.[CrossRef]
    [Google Scholar]
  42. Nuti, S., Rosa, D., Valiante, N. M., Saletti, G., Caratozzolo, M., Dellabona, P., Barnaba, V. & Abrignani, S. ( 1998; ). Dynamics of intra-hepatic lymphocytes in chronic hepatitis C: enrichment for Vα24+ T cells and rapid elimination of effector cells by apoptosis. Eur J Immunol 28, 3448–3455.[CrossRef]
    [Google Scholar]
  43. Okuda, M., Li, K., Beard, M. R., Showalter, L. A., Scholle, F., Lemon, S. M. & Weinman, S. A. ( 2002; ). Mitochondrial injury, oxidative stress and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology 122, 366–375.[CrossRef]
    [Google Scholar]
  44. Park, J. S., Yang, J. M. & Min, M. K. ( 2000; ). Hepatitis C virus nonstructural protein NS4B transforms NIH3T3 cells in cooperation with the Ha-ras oncogene. Biochem Biophys Res Comm 267, 581–589.[CrossRef]
    [Google Scholar]
  45. Ray, R. B., Lagging, L. M., Meyer, K. & Ray, R. ( 1996; ). Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype. J Virol 70, 4438–4443.
    [Google Scholar]
  46. Ruggieri, A., Harada, T., Matsuura, Y. & Miyamura, T. ( 1997; ). Sensitization to Fas-mediated apoptosis by hepatitis C virus core protein. Virology 229, 68–76.[CrossRef]
    [Google Scholar]
  47. Ruther, U., Tripodi, M., Cortese, R. & Wagner, E. F. ( 1987; ). The human alpha-1-antitrypsin gene is efficiently expressed from two tissue-specific promoters in transgenic mice. Nucleic Acids Res 15, 7519–7529.[CrossRef]
    [Google Scholar]
  48. Sakamuro, D., Furukawa, T. & Takegami, T. ( 1995; ). Hepatitis C virus nonstructural protein NS3 transforms NIH 3T3 cells. J Virol 69, 3893–3896.
    [Google Scholar]
  49. Santolini, E., Migliaccio, G. & La Monica, N. ( 1994; ). Biosynthesis and biochemical properties of the hepatitis C virus core protein. J Virol 68, 3631–3641.
    [Google Scholar]
  50. Takamizawa, A., Mori, C., Fuke, I. & 7 other authors ( 1991; ). Structure and organization of the hepatitis C virus genome isolated from human carriers. J Virol 65, 1105–1113.
    [Google Scholar]
  51. Tan, S. L., Nakao, H., He, Y., Vijaysri, S., Neddermann, P., Jacobs, B. L., Mayer, B. J. & Katze, M. G. ( 1999; ). NS5A, a nonstructural protein of hepatitis C virus, binds growth factor receptor-bound protein 2 adaptor protein in a Src homology 3 domain/ligand-dependent manner and perturbs mitogenic signaling. Proc Natl Acad Sci U S A 96, 5533–5538.[CrossRef]
    [Google Scholar]
  52. Tanaka, S., Takenaka, K., Matsumata, T., Mori, R. & Sugimachi, K. ( 1996; ). Hepatitis C virus replication is associated with expression of transforming growth factor-alpha and insulin-like growth factor-II in cirrhotic livers. Dig Dis Sci 41, 208–215.[CrossRef]
    [Google Scholar]
  53. Tomei, L., Failla, C., Santolini, E., De Francesco, R. & La Monica, N. ( 1993; ). NS3 is a serine protease required for processing of hepatitis C virus polyprotein. J Virol 67, 4017–4026.
    [Google Scholar]
  54. Tripodi, M., Perfumo, S., Ali, R., Amicone, L., Abbott, C. & Cortese, R. ( 1990; ). Generation of small mutation in large genomic fragments by homologous recombination: description of the technique and examples of its use. Nucleic Acids Res 18, 6247–6251.[CrossRef]
    [Google Scholar]
  55. Tsai, S. L., Liaw, Y. F., Chen, M. H., Huang, C. Y. & Kuo, G. C. ( 1997; ). Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity. Hepatology 25, 449–458.[CrossRef]
    [Google Scholar]
  56. Woitas, R. P., Lechmann, M., Jung, G., Kaiser, R., Sauerbruch, T. & Spengler, U. ( 1997; ). CD30 induction and cytokine profiles in hepatitis C virus core-specific peripheral blood T lymphocytes. J Immunol 159, 1012–1018.
    [Google Scholar]
  57. Zucchelli, S., Capone, S., Fattori, E. & 8 other authors ( 2000; ). Enhancing B- and T-cell immune response to a hepatitis C virus E2 DNA vaccine by intramuscular electrical gene transfer. J Virol 74, 11598–11607.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.19724-0
Loading
/content/journal/jgv/10.1099/vir.0.19724-0
Loading

Data & Media loading...

Most cited articles

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error